Uncover the 2023 Oncolytic Viruses Landscape

A comprehensive analysis of the drugs, trials, deals, and companies’ landscapes for the Oncolytic Viruses space and regulatory announcements from 2023.

Download Here

About the 2023 Landscape Review

With over 600 oncolytic viruses assets being tracked on our database, some highlights include the surge of Rhabdoviridae viruses as the fastest-growing viral family despite their relatively smaller presence in the overall family space. This shift underscores the evolving nature of virus family data since our last landscape review.

Furthermore, with oncolytic viruses being genetically modified as the leading approach to target cancer cells, you will have the opportunity to delve deeper and uncover which type of genetic modification holds the largest number of assets.

Excited to explore further? If you wish to see an in-depth breakdown of the information above, you can download the 2023 Oncolytic Viruses Landscape report.

You may also be interested in...

The 2023 TPD Landscape Review

Find out more

2023 Oncolytic Viruses Landscape Review

Find out more

2023 Cancer Vaccine Landscape Review

Find out more

Infographic 2023 Oncolytic Viruses ESMO Abstracts Analysis

Find out more

SITC 2023 Oncolytic Viruses Annual Meeting Abstracts

Find out more

H1 2023 Oncolytic Viruses Landscape Review

Find out more

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.

With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.

Discover a database tailored to your needs

Speak with our team

Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.

Get Started